Hemo Bioscience, Research Triangle Park, NC, has received FDA premarket notification (510(k)) clearance for its MQC-CAT, a ready-to-use quality control product for blood bank testing methods that use manual column agglutination technology (CAT). Validated for use in all manual CAT testing systems currently available in the United States, MQC-CAT includes both positive and negative red cells and serums to ensure that ABO, Rh(D), and antibody screening and identification reagents are performing as expected. The product has a 63-day expiration. For more information, visit Hemo Bioscience.